Search for Abstracts Find by Title, Author or Description Year Abstracts - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first C21 - Efficacy and Safety of Peptide Receptor Radionuclide Therapy in Lung Neuroendocrine Tumors: A Multicentre Study Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Iravani, L. Zidan, K. Oleinikov, S. Ben-Haim, D. Gross, A. Meirovitz, O. Maimon, T. Akhurst, M. Michael, R. Hicks, S. Grozinsky-Glasberg, G. Kong ABSTRACT ID: 15 C22 - Patient Travel Concerns After Treatment with Peptide Receptor Radionuclide Therapy (PRRT) Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Kendi, T. Halfdanarson, B. Naraev, D. Mercer, J. Underwood, J. Mailman ABSTRACT ID: 36 C23 - 177Lu-DOTATATE/DOTATOC Re-Treatment in Patients with Progressive Neuroendocrine Tumours: A Systematic Review and Meta-Analysis Published in 2020 Listed under Clinical-PRRT-Nuclear Download J. Strosberg, O. Leeuwenkamp, M.K. Siddiqui ABSTRACT ID: 43 C24 - A Clinical Score(CS) for Well- Differentiated Neuroendocrine Tumor(WD-NET) Patients(Pts) Undergoing Peptide Receptor Radionuclide Therapy(PRRT) Published in 2020 Listed under Clinical-PRRT-Nuclear Download S. Das, L. Du, A. Schad, S. Jain, A. Jessop, C. Shah, D. Eisner, D. Cardin, K. Ciombor, L. Goff, M. Bradshaw, D. Delbeke, M. Sandler, J. Berlin ABSTRACT ID: 44 C25 - The Use of Peptide Receptor Radionucleotide Therapy (PRRT) in Patients with Neuroendocrine Tumor Cardiac Metastases Published in 2020 Listed under Clinical-PRRT-Nuclear Download I. Yu, G. Funk, E. Lin, H. Kennecke ABSTRACT ID: 58 C26 - Safety of 177Lu DOTATATE in Patients with Advanced Neuroendocrine Tumors: Data from a US Expanded Access Program Published in 2020 Listed under Clinical-PRRT-Nuclear Download M. Allen-Auerbach, E. Wolin, V. Nassiri, P. Broberg, G. El-Haddad ABSTRACT ID: 118 C27 - Re-Treatment with 177Lu-DOTATATE in Patients With Neuroendocrine Tumors: Multicenter Real-World Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download S. Navalkissoor, M. Essler, M. Caplin, W. Van Der Zwan, M. Wicharz, W. De Herder, P. Broberg, E. Krenning ABSTRACT ID: 119 C28 - Supportive Management during PRRT for Symptomatic Pheochromocytomas or Paragangliomas Published in 2020 Listed under Clinical-PRRT-Nuclear Download E. Tsang, G. Funk, J. Leung, G. Kalish, H. Kennecke ABSTRACT ID: 134 C29 - Gallium-68 Dotatate PET/CT (Ga68PET/CT) Versus Contrast Enhanced Cross Sectional Imaging (CECSI) to Measure Treatment Response (TR) to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Neuroendocrine Tumors (NETs) Published in 2020 Listed under Clinical-PRRT-Nuclear Download D. Jackson, M. Downey, G. Kalish, E. Mittra, H. Kennecke ABSTRACT ID: 145 C30 - 64Cu-DOTATATE PET in Neuroendocrine Tumor Patients: What We Learned From the First 1,200 Patients Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Kjaer, E. Carlsen, M. Loft, C. Johnbeck, T. Binderup, S. Langer, B. Federspiel, U. Knigge ABSTRACT ID: 147 C31 - PRRT Neuroendocrine Tumor Response Monitored Using Circulating Transcript Analysis: The NETest Published in 2020 Listed under Clinical-PRRT-Nuclear Download L. Bodei, M. Kidd, A. Singh, W. Van Der Zwan, S. Severi, I. Drozdov, A. Malczewska, G. Paganelli, E. Krenning, I. Modlin ABSTRACT ID: 160 C32 - Dynamic Contrast-Enhanced CT to Evaluate Response in Neuroendocrine Liver Metastases Treated with Everolimus and Radiation Published in 2020 Listed under Clinical-PRRT-Nuclear Download J. Hudson, S. Singh, V. Rodriguez-Freixinos, D. Chan, J. Hallet, C. Law, S. Myrehaug ABSTRACT ID: 165 C33 - Association Between Surveillance Imaging and Survival Outcomes in Small Bowel Neuroendocrine Tumors Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Watanabe, L. Yip, G. McKendry, J. Loree, H. Stuart ABSTRACT ID: 167 C34 - An Initial Experience in Establishing a Theranostic Precision Medicine PRRT Targeted Radiotherapy Program for the Treatment of GEP-NETs with Lu-177 Dotatate (Lutathera) in a Major Academic University Hospital Published in 2020 Listed under Clinical-PRRT-Nuclear Download P. Wojtylak, A. Mohamed, N. Avril, A. Kardan ABSTRACT ID: 173 C35 - Real-World Analysis of Safety and Tolerance of Repeat Peptide Receptor Radionuclide Therapy Published in 2020 Listed under Clinical-PRRT-Nuclear Download J. Chau, H. Bakeri, N. Yu, Y. Menda, J. Dillon, C. Chandrasekharan ABSTRACT ID: 192 C36 - 212Pb-AlphaMedixTM Targeted Alpha Therapy (TAT): A Potential Breakthrough in Treatment of Metastatic SSTR Expressing NET Published in 2020 Listed under Clinical-PRRT-Nuclear Download E. Delpassand, I. Tworowska, J. Torgue, J. Hurt, R. Nuñez, R. Esfandiari ABSTRACT ID: 193 C38 - Hepatotoxicity in Previously Treated Y-90 Metastatic Neuroendocrine Cancer Patients after PRRT: Single Institution Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download Y.L. Wong, J. Thomas, A. Shreenivas ABSTRACT ID: 197 C39 - Hematotoxicity of Peptide Receptor Radionuclide Therapy (PRRT) – A Single Institution Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download H. Duan, V. Ferri, P. Kunz, G. Davidzon, F. Moradi, J. Nguyen, B. Franc, A. Iagaru, C. Aparici Mari ABSTRACT ID: 199 C40 - Renal and Hepatotoxicity of Peptide Receptor Radionuclide Therapy (PRRT) – A Single Institution Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download H. Duan, V. Ferri, P. Kunz, G. Davidzon, J. Nguyen, F. Moradi, B. Franc, A. Iagaru, C. Aparici Mari ABSTRACT ID: 201 Select the number of documents per page 5 10 15 20 25 30 50 100
